|By PR Newswire||
|August 20, 2014 12:00 PM EDT||
BURLINGTON, Mass., Aug. 20, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed managed care organizations (MCOs) anticipate that their costs of covering biologic treatments of autoimmune diseases will increase by double-digit rates each year the next two years. The cost trend for rheumatoid arthritis (RA), which MCOs expect to average 19 percent, is a major concern for more than two-thirds of the 40 surveyed MCO pharmacy directors/medical directors. As a result, payers have increased cost controls on biologics, which has affected prescribing by specialists. The survey, which also included 103 rheumatologists, indicates that 80 percent of the specialists encounter moderate-to-strong control by payers when prescribing biologic agents for RA and psoriatic arthritis (PsA), while 74 percent of specialists note this level of control for ankylosing spondylitis (AS).
Other key findings from the U.S. Physician & Payer Forum report High-Cost Biologics for Autoimmune Diseases: How Will Healthcare Reform and Payer-Led Cost-Taming Strategies Impact Brand Prescribing?:
- Prescribing of biologic agents: Close to 60 percent of surveyed rheumatologists said their patients treated for RA, PsA and AS are prescribed a biologic agent—typically after an initial trial and failure of conventional disease modifying antirheumatic drugs.
- Utilization management controls: Among all the restrictions and strategies to control the use of high-cost biologics, MCOs overwhelmingly apply utilization management controls, most commonly prior authorization and step therapy, to steer to preferred agents.
- Adherence to preferred drug lists: In response to increased payer controls, more than half of surveyed rheumatologists reported they adhere more closely to preferred drug lists and plan to do so in the next 12 months.
- Specialty pharmacy use: About half of MCOs reported a specialty pharmacy is commonly used to acquire biologic drugs for members with RA—a trend that may accelerate with the launch of more self-administered therapies, thus increasing the ability of payers to control costs.
- Site of care restrictions: Only 23 percent of MCO directors reported their MCO restricts the site of care of infused therapies; among the rest, 45 percent anticipate adding such restrictions in the next two years.
Comments from Decision Resources Group Analyst Chris Lewis:
- "Autoimmune diseases represent the most costly class of specialty drugs for the nation's payers, and they have responded by enacting controls that encourage prescribers to adhere to treatment protocols and prescribe MCOs' preferred agents. With blockbusters like Enbrel, Humira and Remicade enjoying first-line status, other therapies face the continual challenge of getting prescribed."
- "Considering prescribers intend to adhere more closely to preferred drug lists as a result of increased payer control on biologics, drug marketers need to find ways to obtain preferred brand coverage on MCO formularies or risk losing patient share to competitors that achieve favorable coverage."
- Media members are welcome to attend our upcoming webinar based on this report entitled Taming High-Cost Biologics: The Impact of Payer Restrictions on Prescribing of Autoimmune Therapies. This presentation will be held on Thursday, September 18, 2014. For more information, please contact Christopher Comfort at [email protected].
About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact:
Decision Resources Group
SOURCE Decision Resources Group
Jul. 25, 2016 07:30 AM EDT Reads: 1,993
Jul. 25, 2016 06:30 AM EDT Reads: 1,480
Jul. 25, 2016 06:00 AM EDT Reads: 1,455
Jul. 25, 2016 06:00 AM EDT Reads: 1,748
Jul. 25, 2016 05:45 AM EDT Reads: 1,351
Jul. 25, 2016 05:00 AM EDT Reads: 2,007
Jul. 25, 2016 04:15 AM EDT Reads: 2,396
Jul. 25, 2016 04:15 AM EDT Reads: 1,823
Jul. 25, 2016 04:00 AM EDT Reads: 1,183
Jul. 25, 2016 04:00 AM EDT Reads: 1,838
In addition to all the benefits, IoT is also bringing new kind of customer experience challenges - cars that unlock themselves, thermostats turning houses into saunas and baby video monitors broadcasting over the internet. This list can only increase because while IoT services should be intuitive and simple to use, the delivery ecosystem is a myriad of potential problems as IoT explodes complexity. So finding a performance issue is like finding the proverbial needle in the haystack.
Jul. 25, 2016 03:45 AM EDT Reads: 2,166
With the proliferation of both SQL and NoSQL databases, organizations can now target specific fit-for-purpose database tools for their different application needs regarding scalability, ease of use, ACID support, etc. Platform as a Service offerings make this even easier now, enabling developers to roll out their own database infrastructure in minutes with minimal management overhead. However, this same amount of flexibility also comes with the challenges of picking the right tool, on the right ...
Jul. 25, 2016 03:15 AM EDT Reads: 999
With over 720 million Internet users and 40–50% CAGR, the Chinese Cloud Computing market has been booming. When talking about cloud computing, what are the Chinese users of cloud thinking about? What is the most powerful force that can push them to make the buying decision? How to tap into them? In his session at 18th Cloud Expo, Yu Hao, CEO and co-founder of SpeedyCloud, answered these questions and discussed the results of SpeedyCloud’s survey.
Jul. 25, 2016 03:15 AM EDT Reads: 822
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform. In his session at @ThingsExpo, Craig Sproule, CEO of Metavine, demonstrated how to move beyond today's coding paradigm and shared the must-have mindsets for removing complexity from the develo...
Jul. 25, 2016 01:45 AM EDT Reads: 1,224
SYS-CON Events announced today that MangoApps will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. MangoApps provides modern company intranets and team collaboration software, allowing workers to stay connected and productive from anywhere in the world and from any device.
Jul. 25, 2016 01:30 AM EDT Reads: 1,255